IAM
The Long Read
There is growing evidence that patent litigants are turning to
ex parte reexaminations to bolster their PTAB strategies. Cozen O’Connor’s Jeffrey Townes and Hongling Zou analyse why older USPTO tools deserve a second look and explore how to get best value from them. Read more here
MONDAY 29th March
Semiconductor Energy Laboratory, an R&D-based Japanese business, has expanded its first patent assertion campaign in nearly a decade with a lawsuit targeting TCL’s display affiliate. Read more here
Acacia CEO points to recent “astounding IP settlements and judgments” as signs that the patent market is rebounding. Read more here
How the EPO’s latest CRISPR revocation affects the Cas9 landscape
The revocation of a Sigma-Aldrich Cas9 patent could be a sign of things to come in other EPO opposition proceedings, but Europe’s CRISPR IP state of play will remain uncertain for several years
Returning user? Enter your details below to log into your account.
E-Mail Address: